O
Orchestra Biomed Holdings Inc
NASDAQ:OBIO
Orchestra Biomed Holdings Inc
NASDAQ:OBIO
Price:
4.2
USD
-4.11%
Market Closed
Market Cap:
$237.1m
Relative Value
The Relative Value of one OBIO stock under the Base Case scenario is 0.16 USD. Compared to the current market price of 4.2 USD, Orchestra Biomed Holdings Inc is Overvalued by 96%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OBIO
Relative Value
Base Case
0.16
USD
Overvaluation 96%
O
Multiples Across Competitors
OBIO Competitors Multiples
Orchestra Biomed Holdings Inc Competitors
Orchestra Biomed Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
O
|
Orchestra Biomed Holdings Inc
NASDAQ:OBIO
|
237.2m USD | 84.2 | -3.2 | -2.1 | -2.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.6B USD | 4.2 | 28.8 | 16.5 | 22.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.7B USD | 16.7 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.8B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD | 5.1 | 35.4 | 20.8 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.7 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.5B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.4B USD | 2.1 | 25.8 | 10.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.2 | 30.7 | 34 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
